探讨CKD中药物与代谢紊乱之间的相互作用:以口服抗凝剂为例。

IF 3.2 Q1 UROLOGY & NEPHROLOGY
Kidney360 Pub Date : 2025-06-19 DOI:10.34067/KID.0000000862
Touria Mernissi, Stéphane Jaisson, Pierre Spicher, Said Kamel, Anaïs Okwieka, Julien Demagny, Gabriel Choukroun, Solène M Laville, Sandra Bodeau, Sophie Liabeuf
{"title":"探讨CKD中药物与代谢紊乱之间的相互作用:以口服抗凝剂为例。","authors":"Touria Mernissi, Stéphane Jaisson, Pierre Spicher, Said Kamel, Anaïs Okwieka, Julien Demagny, Gabriel Choukroun, Solène M Laville, Sandra Bodeau, Sophie Liabeuf","doi":"10.34067/KID.0000000862","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The metabolic disturbances associated with chronic kidney disease might alter drug distribution, decrease albumin drug binding, and thus increase the free (unbound) drug concentrations. Uremic toxins can affect the pharmacokinetic or pharmacodynamic activity of certain drugs. Vitamin K antagonists (VKA) are interesting candidates for the evaluation of potential interactions between uremic toxins and drugs. The primary objective of the present study was to investigate the association between free VKA concentrations and the estimated glomerular filtration rate (eGFR). Furthermore, we sought to determine whether this relationship was mediated by protein carbamylation (measured by homocitrulline levels) and/or the accumulation of protein-bound uremic toxins (PBUTs).</p><p><strong>Methods: </strong>In this prospective cross-sectional study, 389 adult patients treated with VKA were included between May 2021 and June 2023. Levels of free VKAs, total VKAs, homocitrulline and PBUTs were assayed using liquid chromatography-tandem mass spectrometry. We used a linear regression model to explore the association between kidney function and free VKA levels and mediation analyses to determine whether the association between kidney function and free VKA levels was mediated (at least partly) by PBUTs and/or protein carbamylation.</p><p><strong>Results: </strong>Patients with an eGFR < 40 mL/min/1.73 m2 or those on chronic hemodialysis had lower total VKA levels, higher free VKA levels and thus a higher of free/total VKA ratio than those with an eGFR ≥ 40 mL/min/1.73 m2. Kidney function was independently associated with free VKA levels (β1=0.31 [0.19; 0.42], p<0.001). Twenty one percent [95%CI, 1%-35%] of the association between kidney function and free VKA levels was mediated by homocitrulline, but not by PBUTs.</p><p><strong>Conclusions: </strong>Our results showed that a low kidney function was associated with an elevation in the free drug fraction. This association was independent of blood albumin levels and appeared to be partly mediated by protein carbamylation.</p>","PeriodicalId":17882,"journal":{"name":"Kidney360","volume":" ","pages":""},"PeriodicalIF":3.2000,"publicationDate":"2025-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Exploring the Interactions between Drugs and Metabolic Disturbances in CKD: An Example with Oral Anticoagulants.\",\"authors\":\"Touria Mernissi, Stéphane Jaisson, Pierre Spicher, Said Kamel, Anaïs Okwieka, Julien Demagny, Gabriel Choukroun, Solène M Laville, Sandra Bodeau, Sophie Liabeuf\",\"doi\":\"10.34067/KID.0000000862\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The metabolic disturbances associated with chronic kidney disease might alter drug distribution, decrease albumin drug binding, and thus increase the free (unbound) drug concentrations. Uremic toxins can affect the pharmacokinetic or pharmacodynamic activity of certain drugs. Vitamin K antagonists (VKA) are interesting candidates for the evaluation of potential interactions between uremic toxins and drugs. The primary objective of the present study was to investigate the association between free VKA concentrations and the estimated glomerular filtration rate (eGFR). Furthermore, we sought to determine whether this relationship was mediated by protein carbamylation (measured by homocitrulline levels) and/or the accumulation of protein-bound uremic toxins (PBUTs).</p><p><strong>Methods: </strong>In this prospective cross-sectional study, 389 adult patients treated with VKA were included between May 2021 and June 2023. Levels of free VKAs, total VKAs, homocitrulline and PBUTs were assayed using liquid chromatography-tandem mass spectrometry. We used a linear regression model to explore the association between kidney function and free VKA levels and mediation analyses to determine whether the association between kidney function and free VKA levels was mediated (at least partly) by PBUTs and/or protein carbamylation.</p><p><strong>Results: </strong>Patients with an eGFR < 40 mL/min/1.73 m2 or those on chronic hemodialysis had lower total VKA levels, higher free VKA levels and thus a higher of free/total VKA ratio than those with an eGFR ≥ 40 mL/min/1.73 m2. Kidney function was independently associated with free VKA levels (β1=0.31 [0.19; 0.42], p<0.001). Twenty one percent [95%CI, 1%-35%] of the association between kidney function and free VKA levels was mediated by homocitrulline, but not by PBUTs.</p><p><strong>Conclusions: </strong>Our results showed that a low kidney function was associated with an elevation in the free drug fraction. This association was independent of blood albumin levels and appeared to be partly mediated by protein carbamylation.</p>\",\"PeriodicalId\":17882,\"journal\":{\"name\":\"Kidney360\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.2000,\"publicationDate\":\"2025-06-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Kidney360\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.34067/KID.0000000862\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kidney360","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34067/KID.0000000862","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:与慢性肾脏疾病相关的代谢紊乱可能改变药物分布,降低白蛋白药物结合,从而增加游离(未结合)药物浓度。尿毒症毒素可影响某些药物的药代动力学或药效学活性。维生素K拮抗剂(VKA)是评估尿毒症毒素与药物之间潜在相互作用的有趣候选者。本研究的主要目的是研究游离VKA浓度与肾小球滤过率(eGFR)之间的关系。此外,我们试图确定这种关系是否由蛋白质氨基甲酰化(通过高瓜氨酸水平测量)和/或蛋白质结合尿毒症毒素(PBUTs)的积累介导。方法:在这项前瞻性横断面研究中,在2021年5月至2023年6月期间纳入了389名接受VKA治疗的成年患者。采用液相色谱-串联质谱法测定游离VKAs、总VKAs、均氨酸和PBUTs的含量。我们使用线性回归模型来探索肾功能和游离VKA水平之间的关联,并进行中介分析,以确定肾功能和游离VKA水平之间的关联是否(至少部分)由PBUTs和/或蛋白质氨基化介导。结果:与eGFR≥40 mL/min/1.73 m2的患者相比,eGFR < 40 mL/min/1.73 m2的患者总VKA水平较低,游离VKA水平较高,游离/总VKA比值较高。肾功能与游离VKA水平独立相关(β1=0.31 [0.19;[0.42]结论:我们的研究结果表明,肾功能低下与游离药物含量升高有关。这种关联与血白蛋白水平无关,似乎部分由蛋白氨基化介导。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Exploring the Interactions between Drugs and Metabolic Disturbances in CKD: An Example with Oral Anticoagulants.

Background: The metabolic disturbances associated with chronic kidney disease might alter drug distribution, decrease albumin drug binding, and thus increase the free (unbound) drug concentrations. Uremic toxins can affect the pharmacokinetic or pharmacodynamic activity of certain drugs. Vitamin K antagonists (VKA) are interesting candidates for the evaluation of potential interactions between uremic toxins and drugs. The primary objective of the present study was to investigate the association between free VKA concentrations and the estimated glomerular filtration rate (eGFR). Furthermore, we sought to determine whether this relationship was mediated by protein carbamylation (measured by homocitrulline levels) and/or the accumulation of protein-bound uremic toxins (PBUTs).

Methods: In this prospective cross-sectional study, 389 adult patients treated with VKA were included between May 2021 and June 2023. Levels of free VKAs, total VKAs, homocitrulline and PBUTs were assayed using liquid chromatography-tandem mass spectrometry. We used a linear regression model to explore the association between kidney function and free VKA levels and mediation analyses to determine whether the association between kidney function and free VKA levels was mediated (at least partly) by PBUTs and/or protein carbamylation.

Results: Patients with an eGFR < 40 mL/min/1.73 m2 or those on chronic hemodialysis had lower total VKA levels, higher free VKA levels and thus a higher of free/total VKA ratio than those with an eGFR ≥ 40 mL/min/1.73 m2. Kidney function was independently associated with free VKA levels (β1=0.31 [0.19; 0.42], p<0.001). Twenty one percent [95%CI, 1%-35%] of the association between kidney function and free VKA levels was mediated by homocitrulline, but not by PBUTs.

Conclusions: Our results showed that a low kidney function was associated with an elevation in the free drug fraction. This association was independent of blood albumin levels and appeared to be partly mediated by protein carbamylation.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Kidney360
Kidney360 UROLOGY & NEPHROLOGY-
CiteScore
3.90
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信